CSF COPPER CONCENTRATION - A NEW PARAMETER FOR DIAGNOSIS AND MONITORING THERAPY OF WILSONS-DISEASE WITH CEREBRAL MANIFESTATION

被引：33

作者：

WEISNER, B ^{[1
]}

HARTARD, C ^{[1
]}

DIEU, C ^{[1
]}

机构：

[1] UNIV HAMBURG,NEUROL KLIN,D-2000 HAMBURG 20,FED REP GER

来源：

关键词：

D O I：

10.1016/0022-510X(87)90275-9

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：229 / 237

页数：9

共 23 条

[11] NUCLEAR MAGNETIC-RESONANCE (NMR) IMAGING IN WILSON DISEASE [J].

LAWLER, GA ;

PENNOCK, JM ;

STEINER, RE ;

JENKINS, WJ ;

SHERLOCK, S ;

YOUNG, IR .

[12]

MULLERJENSEN A, 1983, ELECTROENCEPHALOGR C, V56, P139

[13]

NIX WA, 1984, NERVENARZT, V55, P544

[14]

Scheinberg IH, 1984, MAJOR PROBLEMS INTER, VXXIII

[15]

SCHOENBERGER M, 1979, ARCH OPHTHALMOL-CHIC, V97, P1914

[16]

STERNLIEB I, 1979, GASTROENTEROLOGY, V77, P138

[17]

THOMAS L, 1984, LABOR DIAGNOSE, P297

[18]

TYRER SP, 1979, AM J PSYCHIAT, V136, P937

[19]

WALSHE JM, 1982, LANCET, V1, P643

[20]

WALSHE JM, 1973, Q J MED, V42, P441